CNS considers itself well versed in the needs of both Australian and non-Australian clients as it has worked with many local, US and European clients since it inception in 1998. Indeed, several CNS team members have worked for US and European-based companies and in several cases were based in those countries adding to our understanding of our client’s expectations. As a small boutique CRO, CNS is proud of its low staff turnover and high client retention.
Prof Tony (AJ) Webber – CEO & Executive Director"CNS was established as a specialist CRO with the aim of assisting small to medium size pharmaceutical and biotechnology companies manage product development for their potential therapeutic emerging from pre-clinical studies, through “proof of concept” and “first in man”. Using a network of Australian and New Zealand Phase I units and specialist clinical sites and its highly experienced team CNS continues to meet this aim."
Russell Neal - Director of OperationsRussell has been advising clients in clinical trial management for over 15 years. Initially as a CRA/PM, he moved with Quintiles to Sydney before moving to Singapore in 1999. In 2003, Russell returned to Australia following three years as Regional Training Manager Asia Pacific and is currently Director of Operations at CNS, where he is responsible for the day to day running of CNS' business.
"The unique blend of backgrounds and experience that we have at CNS gives us a great insight into our clients. We find it an advantage being a small delivery-focussed company enabling us to be as flexible as our clients require us to be. We believe we can add an independent, quality driven perspective to our clients programs, whether we contribute in whole or just in part."
Gabrielle
McKee – Director of Clinical Operations Over 12 years managing clinical teams and projects at international CROs and local biotechnology companies.
"Helping to bring new technology and treatments into the international market place from Australia has always been a personal dream; that we are doing this everyday with a fantastic team of very qualified, experienced clinical research professionals is a delight. CNS' unique business model has grown around the needs of our clients and the needs of our team of expert consultants, a balance that we strive to maintain and foster in every aspect of our work."
